Press releases

Fraunhofer IPK and Charité – Universitätsmedizin Berlin are jointly researching a new approach for the effective, safe and cost-efficient treatment of autoimmune patients.

The manufacturing of the future will be data-driven, but in order to get there, there is still a lot of development work to be done. Fraunhofer IPK presents research projects, technologies and solutions that respond to the challenges and needs of manufacturing companies.

A new real-world laboratory was opened today at the 4th ReTraNetz-BB network forum at the Production Technology Center (PTZ) in Berlin. The laboratory supports the transformation of the vehicle and supplier industry in the Berlin-Brandenburg region and provides a forward-looking space for the transformation of mobility.

Even though artificial intelligence and autonomous solutions are increasingly conquering manufacturing, nothing works in production without qualified employees. Providing the best possible support for people in production, transferring their knowledge and maintaining their ability to work for as long as possible is becoming increasingly important for companies, a trend report by Fraunhofer IPK makes clear.

Even if the central concern of digitally integrated production or Industry 4.0 is networking industrial systems – the individual machine remains a central focus point of optimization. The reasons: Networking requires interfaces that must first be implemented on the individual machine. Fraunhofer IPK discussed the challenges facing machine builders in the development of intelligent mechatronic system technology with experts as part of a trend report.

For a growing number of companies, sustainability is no longer just a marketing argument, but an economic necessity. In times of supply bottlenecks for raw materials and rising energy prices, using scarce and expensive resources efficiently is gaining importance, as Fraunhofer IPK shows in a trend report.

»BioFusion 4.0« transfers principles from nature into industrial manufacturing to achieve sustainable and circular value creation. At this year‘s Hannover Messe from April 17 to 21, 2023, Fraunhofer IPK demonstrates how biogenic materials and digital solutions can be used to design resilient production processes and sustainable products.

mRNA-based vaccines have been one of the key elements in the fight against the coronavirus. The technology was originally developed for cancer therapy and can be used to treat many diseases. Together with partners from science and industry, Fraunhofer IPK is now researching how mRNA therapeutics and other medication can be better produced and more effectively applied.

The Fraunhofer IPK Project Office at Instituto Tecnológico de Aeronáutica (ITA) in São José dos Campos facilitates application-oriented research and development for the Brazilian manufacturing industry.

For a long time, there was no alternative to rigid production structures when fast throughput was required. Now they are becoming obsolete, as Fraunhofer IPK shows in its trend report. Instead of highly integrated, firmly linked lines, manufacturing experts increasingly favor modular production systems that can be flexibly combined.